Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measure...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Pedersen, Katrina S., Bamlet, William R., Oberg, Ann L., de Andrade, Mariza, Matsumoto, Martha E., Tang, Hui, Thibodeau, Stephen N., Petersen, Gloria M., Wang, Liang
Format:	Artigo
Sprog:	Inglês
Udgivet:	Public Library of Science 2011
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3063802/ https://ncbi.nlm.nih.gov/pubmed/21455317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018223
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

Lignende værker